MedPath

Aquesys, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma

Not Applicable
Completed
Conditions
Glaucoma
Glaucoma, Open Angle
Interventions
Device: AqueSys XEN 45 Glaucoma Implant
First Posted Date
2014-01-15
Last Posted Date
2017-06-01
Lead Sponsor
AqueSys, Inc.
Target Recruit Count
65
Registration Number
NCT02036541
Locations
🇺🇸

Stiles Eyecare Excellence & Glaucoma Institute, Overland Park, Kansas, United States

🇺🇸

Montebello Eye Center, Montebello, California, United States

🇺🇸

San Diego Eye Care Center, Oceanside, California, United States

and more 9 locations

Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants

Phase 4
Completed
Conditions
Primary Open Angle Glaucoma
Interventions
Device: XEN® Gel Stent
Procedure: Cataract Surgery
First Posted Date
2013-12-10
Last Posted Date
2019-04-22
Lead Sponsor
AqueSys, Inc.
Target Recruit Count
199
Registration Number
NCT02006693
Locations
🇦🇹

University of Graz, Graz, Austria

🇦🇹

Vienna University, Vienna, Austria

🇵🇱

Ophthalmology Department of the Military Health Service Institute, Warsaw, Poland

and more 18 locations

AqueSys Microfistula Implant in Refractory Glaucoma

Phase 3
Completed
Conditions
Glaucoma, Open-Angle
Glaucoma
Interventions
Device: AqueSys Microfistula Implant
First Posted Date
2012-07-16
Last Posted Date
2016-02-08
Lead Sponsor
AqueSys, Inc.
Target Recruit Count
60
Registration Number
NCT01640756
Locations
🇺🇸

Vold Vision, PLLC, Fayetteville, Arkansas, United States

🇺🇸

Ophthalmic Consultants of Connecticut, Fairfield, Connecticut, United States

🇺🇸

USC Eye Institute, University of Southern California, Los Angeles, California, United States

and more 11 locations
© Copyright 2025. All Rights Reserved by MedPath